Arovella Therapeutics (ASX:ALA) said Chairman Thomas Duthy will retire from his role, effective Tuesday, to pursue new business opportunities, according to a Monday filing with the Australian bourse.
The board has appointed Elizabeth Stoner as interim chair while the company conducts a comprehensive search for a new chair, the filing added.
The company's shares tumbled 9% in recent Monday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.